Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Sysmex Introduces Automated Urinalysis Testing Solutions that Revolutionize Workflow at Medlab Middle East 2023

By LabMedica International staff writers
Posted on 07 Feb 2023

Sysmex Corporation (Kobe, Japan) is presenting its broad range of medical diagnostics products and solutions in the fields of hematology, urinalysis, haemostasis and flow cytometry at Medlab Middle East 2023. More...

At Medlab Middle East 2023, taking place 6-9 February in Dubai, Sysmex is showcasing the BloodScience Workcell which smartly combines hematology and haemostasis testing in one interdisciplinary solution – to support physicians in obtaining a more holistic picture of their patients and to improve the workflow in the laboratory. Sysmex’s novel laboratory automation concept consolidates the workflow automation of EDTA and citrate blood sample tubes by combining haematology’s XN-9100 with the new CN track for haemostasis. Both automation lines are physically connected through the tube sorter TS-10 while the capabilities of the Extended IPU facilitate a standardized work area management for hematology and haemostasis. One user can operate this automation platform that harmonizes high workload capacities for citrate and EDTA blood specimens. A safe and completely closed tube system with cap piercing functionality, it effectively reduces the biohazard risk.

Sysmex is also highlighting its modular, integrated clinical flow cytometry system that helps labs efficiently manage sample and data flow, covering the steps from sample preparation through to analysis and reporting. For instance, the programmable PS-10 from Sysmex automates sample preparation steps to match SOPs, adding increased efficiency and standardization for complex and routine flow cytometry applications. The Hettich Rotolavit II-S cell wash centrifuge automatically carries out the routine washing steps when preparing samples for flow cytometry while the award-winning Silent Design of the XN-Series set the standard for the development of this 10-colour flow cytometer for highest-level clinical requirements.

Sysmex is also presenting its urinalysis solutions that can support the diagnosis of common diseases such as urinary tract infections, kidney diseases and others. This includes the UN-Series that can automate the lab’s urinalysis work area according to workflow preferences. With modular components to mix and match, labs can tailor a complete solution that is scalable to their current and future needs, providing a perfect fit while securing your investment. While the UN-Series can cover the complete urinalysis workflow it offers labs maximum flexibility in setting up their desired workflow. Because of its modularity, labs can configure their solution to cover only the parts they require. Whatever the selection, there will be no more hands-on urinalysis as the whole process is automated, and labs get all the results on one screen, with all data centralized in one workstation.

Related Links:
Sysmex Corporation


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Platelet Function Analyzer
PL-12
Automated Clinical Chemistry Analyzer
Envoy 500+
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The researchers Manel Pérez Pons y Carlos Rodriguez Muñoz at the IRBLleida laboratory (Photo courtesy of IRBLleida)

New Blood RNA Markers Help Advance Precision Medicine for Respiratory Patients

Risk stratification in hospitalized respiratory disease, particularly among older adults with COVID-19, remains challenging despite rich clinical datasets. Blood-based non-coding RNA biomarkers are promising,... Read more

Microbiology

view channel
Image: The “broth” used to monitor red blood cell depletion in whole blood spiked with one colony-forming-unit of E. coli bacteria, each incubated at different orbital shaking speeds—left to right: 0 RPM, 65 RPM, 120 RPM and 200 RPM—after four hours of incubation. This culturing raises a bacteria-rich, plasma-like layer of bacteria to the top of the vials, while clusters of stuck blood cells known as a Rouleaux formation sink to the bottom. (Image Credit: Pak Kin Wong)

New Diagnostic Workflow Identifies Bloodstream Pathogens and Antibiotic Response in Hours

Sepsis is a life-threatening complication of infection that affects more than 1.5 million patients annually in the United States and contributes to roughly one in three in-hospital deaths.... Read more

Pathology

view channel
Image: Researchers evaluated AI models that quantify tumor-infiltrating lymphocytes (TIL) on routine breast tissue slides, where higher TIL levels reflect stronger antitumor response and improved breast cancer outcomes (Image Credit: Shutterstock)

AI Matches Pathologists in Predicting Breast Cancer Prognosis from Immune Cells

Breast cancer is the most common cancer in Australian women, with more than 20,000 cases each year. Prognosis can be informed by counting tumor-infiltrating lymphocytes (TILs) on routine pathology slides,... Read more

Industry

view channel
Image: RaDaR ST uses a tumor-informed approach that identifies up to 48 patient-specific variants through whole-exome sequencing and tracks those variants in plasma to detect circulating tumor DNA (ctDNA) at very low variant allele fractions (VAFs) (Photo courtesy of Neogenomics)

Tumor-Informed MRD Assay Gains Medicare Coverage for Immunotherapy Monitoring

NeoGenomics’ RaDaR ST molecular residual disease (MRD) assay has received expanded coverage from the Centers for Medicare & Medicaid Services’ Molecular Diagnostic Services Program (MolDX) for monitoring... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.